RA
XRAY icon

Royce & Associates’s Dentsply Sirona XRAY Stock Holding History

Royce & Associates’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.99M Buy
847,486
+391,810
+86% +$4.28M 0.07% 401
2026
Q1 		$5.29M Buy
+455,676
New +$5.68M 0.05% 455
2025
Q4 		– Sell
-11,595
Closed -$147K – 824
2025
Q3 		$147K Buy
11,595
+892
+8% +$12.9K ﹤0.01% 748
2025
Q2 		$170K Sell
10,703
-892
-8% -$13.3K ﹤0.01% 758
2025
Q1 		$173K Hold
11,595
– – ﹤0.01% 769
2024
Q4 		$220K Buy
+11,595
New +$245K ﹤0.01% 796
2019
Q1 		– Sell
-5,000
Closed -$186K – 1194
2018
Q4 		$186K Sell
5,000
-68,200
-93% -$2.48M ﹤0.01% 982
2018
Q3 		$2.76M Sell
73,200
-31,985
-30% -$1.33M 0.02% 754
2018
Q2 		$4.6M Hold
105,185
– – 0.03% 612
2018
Q1 		$5.29M Hold
105,185
– – 0.04% 556
2017
Q4 		$6.92M Sell
105,185
-4,700
-4% -$299K 0.05% 500
2017
Q3 		$6.57M Sell
109,885
-16,765
-13% -$997K 0.04% 497
2017
Q2 		$8.21M Buy
126,650
+24,000
+23% +$1.52M 0.05% 443
2017
Q1 		$6.41M Buy
102,650
+26,750
+35% +$1.61M 0.04% 506
2016
Q4 		$4.38M Buy
75,900
+6,900
+10% +$408K 0.03% 616
2016
Q3 		$4.1M Buy
69,000
+3,000
+5% +$184K 0.03% 659
2016
Q2 		$4.09M Buy
66,000
+10,000
+18% +$616K 0.03% 643
2016
Q1 		$3.45M Sell
56,000
-2,900
-5% -$171K 0.02% 705
2015
Q4 		$3.58M Sell
58,900
-14,700
-20% -$874K 0.02% 713
2015
Q3 		$3.72M Hold
73,600
– – 0.02% 717
2015
Q2 		$3.79M Hold
73,600
– – 0.02% 792
2015
Q1 		$3.75M Sell
73,600
-169,528
-70% -$8.74M 0.01% 807
2014
Q4 		$13M Buy
243,128
+3,140
+1% +$160K 0.04% 506
2014
Q3 		$10.9M Buy
239,988
+7,400
+3% +$348K 0.04% 578
2014
Q2 		$11M Sell
232,588
-19,730
-8% -$918K 0.03% 632
2014
Q1 		$11.6M Buy
252,318
+2,000
+0.8% +$92.6K 0.03% 611
2013
Q4 		$12.1M Buy
250,318
+153,800
+159% +$7.2M 0.03% 598
2013
Q3 		$4.19M Buy
+96,518
New +$4.12M 0.01% 894

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Royce & Associates's XRAY Position: Q2 2026 in Review

Royce & Associates increased its Dentsply Sirona (XRAY) stake by 86% in Q2 2026, buying an estimated $4.28M and bringing the position to 847,486 shares worth $8.99M. The position accounts for 0.07% of the portfolio, ranked #401.

Royce & Associates first reported a position in XRAY in Q3 2013 and has held it in 28 quarters since. The position peaked at $13M in Q4 2014. 373 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Royce & Associates held 847,486 shares of Dentsply Sirona worth $8.99M as of Q2 2026.
  • Royce & Associates bought 391,810 Dentsply Sirona shares in Q2 2026, an estimated $4.28M.
  • Dentsply Sirona made up 0.07% of Royce & Associates's portfolio in Q2 2026, its #401 holding.
  • Royce & Associates first reported a position in Dentsply Sirona in Q3 2013 and has held it in 28 quarters since.
  • Royce & Associates's Dentsply Sirona position peaked at $13M in Q4 2014.
  • 373 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.